Vitiligo treatments: review of current therapeutic modalities and JAK inhibitors

KN Cunningham, D Rosmarin - American journal of clinical dermatology, 2023 - Springer
Vitiligo is a chronic autoimmune disease characterized by loss of pigment of the skin,
affecting 0.5–2% of the population worldwide. It can have a significant impact on patients' …

Using a Topical Formulation of Vitamin D for the Treatment of Vitiligo: A Systematic Review

K Al-Smadi, M Ali, SE Alavi, X Jin, M Imran… - Cells, 2023 - mdpi.com
Vitamin D is one significant prohormone substance in human organ systems. It is a steroidal
hormone produced in the skin upon exposure to UVB rays. This paper presents a systematic …

British Association of Dermatologists guidelines for the management of people with vitiligo 2021

V Eleftheriadou, R Atkar, J Batchelor… - British Journal of …, 2022 - academic.oup.com
British Association of Dermatologists guidelines for the management of people with vitiligo 2021*
| British Journal of Dermatology | Oxford Academic Skip to Main Content Advertisement intended …

Evaluation of the efficacy of transdermal drug delivery of calcipotriol plus betamethasone versus tacrolimus in the treatment of vitiligo

ZA Ibrahim, GF Hassan, HY Elgendy… - Journal of cosmetic …, 2019 - Wiley Online Library
Background Vitiligo is a common pigmentary disorder affecting about 1% of the general
population. There are numerous medical and surgical treatments. Microneedling is an …

Promising Functions of Novel Vitamin D Derivatives as Cosmetics: A New Fountain of Youth in Skin Aging and Skin Protection

Z Janjetovic, AT Slominski - Cosmetics, 2024 - mdpi.com
Vitamin D is a natural photoproduct that has many beneficial effects on different organs,
including skin. Active forms of vitamin D and its derivatives exert biological effects on skin …

The emerging role of regulatory T cells in the immunopathogenesis of vitiligo and implications for treatment

Y Liu, Z Liu, D Li, X He, L Xiang, B Li… - British Journal of …, 2024 - academic.oup.com
Vitiligo is an autoimmune skin disease that targets pigment-producing melanocytes and
results in depigmentation. This disfiguring condition frequently affects visible areas of the …

A preliminary study of fractional CO2 laser added to topical tacrolimus combined with 308 nm excimer lamp for refractory vitiligo

X Wen, MR Hamblin, Y Xian, Y Li - Dermatologic therapy, 2019 - Wiley Online Library
Fractional CO2 laser has been proposed recently to be effective and well tolerated in
patients with refractory vitiligo. In this preliminary, prospective study, 21 patients with …

A comparative study on the use of fractional CO2 laser with tacrolimus or calcipotriol or narrow band ultraviolet‐B in treatment of stable nonsegmental vitiligo

RM Bakr, RM Abdel‐Gaber, YM Tawfik - Dermatologic Therapy, 2021 - Wiley Online Library
Conventional methods of treatment for vitiligo are often unsatisfactory to the patients and
time consuming, new treatment modalities are needed. This study was conducted to …

Recent advances in pathogenesis and medical management of vitiligo

M Razmi T, D Parsad - Pigmentary Skin Disorders, 2018 - Springer
Vitiligo is a common pigmentary disorder characterised by the loss of functioning
melanocytes from the basal layer of epidermis, leaving behind depigmented patches on the …

Topical vitamin D analogs

M Polat, Ö Uzun - Comprehensive Textbook on Vitiligo, 2020 - taylorfrancis.com
Vitiligo is a depigmenting disease characterized by the loss of normal melanin pigments in
the skin. The etiology of this disorder is unknown, but autoimmunity is thought to play an …